Doyle Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Doyle Wealth Management's AMGN Position: Q3 2022 in Review
Doyle Wealth Management reduced its Amgen (AMGN) stake by 70% in Q3 2022, selling an estimated $5.58M and leaving 9,869 shares worth $2.23M. The position accounts for 0.19% of the portfolio, ranked #78.
Doyle Wealth Management first reported a position in AMGN in Q1 2017 and has held it in 23 quarters since. The position peaked at $10.5M in Q2 2021. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Doyle Wealth Management held 9,869 shares of Amgen worth $2.23M as of Q3 2022.
- Doyle Wealth Management sold 23,030 Amgen shares in Q3 2022, an estimated $5.58M.
- Amgen made up 0.19% of Doyle Wealth Management's portfolio in Q3 2022, its #78 holding.
- Doyle Wealth Management first reported a position in Amgen in Q1 2017 and has held it in 23 quarters since.
- Doyle Wealth Management's Amgen position peaked at $10.5M in Q2 2021.
- 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Doyle Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.